Edwards IR, Aronson JK. Adverse drug reactions: definitions,
diagnosis, and management. Lancet. 2000;356(9237):1255–1259.
https://doi.org/10.1016/S0140-6736(00)02799-9.
Zambernardi A, Label M. Reacciones cutáneas adversas a
medicamentos: cómo identificar el desencadenante. Actas
Dermosifiliogr. 2018;109(8):699–707....
Bettuzzi T, Sanchez-Pena P, Lebrun-Vignes B. Cutaneous
adverse drug reactions. Therapie. 2024;79(2):239–270. https://
doi.org/10.1016/j.therap.2023.09.011.
Gelincik A, Cavkaytar O, Kuyucu S. An update on the
management of severe cutaneous drug hypersensitivity
reactions. Curr Pharm Des. 2019;25(36):3881–3901....
Ackerman AB, Chongchitnant N, Sanchez JL, et al. Histologic
diagnosis of inflammatory skin diseases. 2nd ed. Baltimore,
MD: Williams &...
Justiniano H, Berlingeri-Ramos AC, Sánchez JL. Pattern analysis of drug-induced skin diseases. Am J Dermatopathol. 2008;30
(4):352–369. https://doi.org/10.1097/DAD.0b013e3181722ef4.
Weyers W, Metze D. Histopathology of drug eruptions: general
criteria, common patterns, and differential diagnosis. Dermatol
Pract Concept....
Barzilai A, Sagi L, Baum S, et al. The histopathology of urticaria
revisited—clinical pathological study. Am J Dermatopathol.
2017;39(10):753–759....
Peroni A, Colato C, Schena D, et al. Urticarial lesions: if not
urticaria, what else? The differential diagnosis of urticaria: part
I. Cutaneous...
Carlson JA, Chen KR. Cutaneous vasculitis update: small
vessel neutrophilic vasculitis syndromes. Am J Dermatopathol.
2006;28(6):486–506....
Batista M, Calado R, Gil F, et al. Histopathology of chronic
spontaneous urticaria with occasional bruising lesions is not
significantly different...
Puhl V, Bonnekoh H, Scheffel J, et al. A novel histopathological
scoring system to distinguish urticarial vasculitis from
chronic spontaneous...
Naim M, Weyers W, Metze D. Histopathologic features of
exanthematous drug eruptions of the macular and papular
type. Am J Dermatopathol. 2011;33(7):695–704....
Ernst M, Giubellino A. Histopathologic features of
maculopapular drug eruption. Dermatopathology (Basel). 2022;9
(3):111–121. https://doi.org/10.3390/
dermatopathology9020014.
Cabañas R, Ramírez E, Sendagorta E, et al. Spanish guidelines
for diagnosis, management, treatment, and prevention of
DRESS syndrome. J Investig...
Kardaun SH, Sekula P, Valeyrie-Allanore L, et al. RegiSCAR study
group. Drug reaction with eosinophilia and systemic symptoms
(DRESS): an...
Skowron F, Bensaid B, Balme B, et al. Comparative histological
analysis of drug-induced maculopapular exanthema and
DRESS. J Eur Acad Dermatol...
Laguna C, Martín B, Torrijos A, et al. Síndrome de StevensJohnson y necrólisis epidérmica tóxica: experiencia clínica y
revisión de la literatura...
Valeyrie-Allanore L, Bastuji-Garin S, Guégan S, et al. Prognostic value of histologic features of toxic epidermal necrolysis. J
Am Acad Dermatol....
Shah H, Parisi R, Mukherjee E, et al. Update on Stevens-Johnson
syndrome and toxic epidermal necrolysis: diagnosis and
management. Am J Clin...
Patel S, John AM, Handler MZ, et al. Fixed drug eruptions: an
update, emphasizing the potentially lethal generalized bullous
fixed drug eruption....
Parisi R, Shah H, Navarini AA, et al. Acute generalized
exanthematous pustulosis: clinical features, differential diagnosis, and management....
Sidoroff A, Halevy S, Bavinck JNB, et al. Acute generalized
exanthematous pustulosis (AGEP) – a clinical reaction pattern:
acute generalized...
Fayos Gregori R, Labrandero Hoyos C, Leal RP, et al. Reacciones
adversas dermatológicas en pacientes con terapia dirigida
contra inhibidores...
